Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab
Linda Myrin-Westesson
Sahlgrenska University Hospital, Department of Medicine, Sahlgrenska Academy, Institution for Nursing Science and Health at Gothenburg UniversityGothenburg,
Orcid profileSearch for this author on
and Anna Olsson
Sahlgrenska University Hospital, Department of Medicine, Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of GothenburgGothenburg,
Orcid profileSearch for this author on
Sep 09, 2025
About this article
Article Category: Clinical Research
Published Online: Sep 09, 2025
Page range: 87 - 95
DOI: https://doi.org/10.2478/jhp-2025-0011
Keywords
© 2025 Linda Myrin-Westesson et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Myrin-Westesson, Linda
Sahlgrenska University Hospital, Department of Medicine, Sahlgrenska Academy, Institution for Nursing Science and Health at Gothenburg UniversityGothenburg
Olsson, Anna
Sahlgrenska University Hospital, Department of Medicine, Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of GothenburgGothenburg